|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
1 | AN ACT concerning public health.
| ||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||
4 | Section 1. Short title. This Act may be cited as the Drug | ||||||||||||||||||||||||
5 | Overdose Prevention Act. | ||||||||||||||||||||||||
6 | Section 5. Definitions. In this Act: | ||||||||||||||||||||||||
7 | "Opioid antagonist" means naloxone hydrochloride or any | ||||||||||||||||||||||||
8 | other similarly acting and equally safe drug approved by the | ||||||||||||||||||||||||
9 | federal Food and Drug Administration for the treatment of drug | ||||||||||||||||||||||||
10 | overdose.
| ||||||||||||||||||||||||
11 | "Department" means the Department of Public Health. | ||||||||||||||||||||||||
12 | "Director" means the Director of Public Health.
| ||||||||||||||||||||||||
13 | Section 10. Reports of drug overdose. | ||||||||||||||||||||||||
14 | (a) The Director shall publish a report on drug overdose | ||||||||||||||||||||||||
15 | trends statewide that reviews State death rates from available | ||||||||||||||||||||||||
16 | data to ascertain changes in the causes or rates of fatal and | ||||||||||||||||||||||||
17 | nonfatal drug overdose for the preceding period of not less | ||||||||||||||||||||||||
18 | than 5 years. The report shall also provide information on | ||||||||||||||||||||||||
19 | interventions that would be effective in reducing the rate of | ||||||||||||||||||||||||
20 | fatal or nonfatal drug overdose. | ||||||||||||||||||||||||
21 | (b) The report shall include: | ||||||||||||||||||||||||
22 | (1) trends in drug overdose death rates; | ||||||||||||||||||||||||
23 | (2) trends in emergency room utilization related to | ||||||||||||||||||||||||
24 | drug overdoses and the cost impact of emergency room | ||||||||||||||||||||||||
25 | utilization; | ||||||||||||||||||||||||
26 | (3) trends in utilization of pre-hospital and | ||||||||||||||||||||||||
27 | emergency services and the cost impact of emergency | ||||||||||||||||||||||||
28 | services utilization; | ||||||||||||||||||||||||
29 | (4) suggested improvements in data collection; and | ||||||||||||||||||||||||
30 | (5) a description of other interventions effective in | ||||||||||||||||||||||||
31 | reducing the rate of fatal or nonfatal drug overdoses. |
| |||||||
| |||||||
1 | Section 15. Programs; drug overdose prevention. | ||||||
2 | (a) The Director shall establish a program to provide for | ||||||
3 | the production and publication of drug overdose prevention, | ||||||
4 | recognition, and response literature. The program shall also | ||||||
5 | provide assistance in the development of curricula for use by | ||||||
6 | professionals, organizations, individuals, or committees | ||||||
7 | interested in the prevention of fatal and nonfatal drug | ||||||
8 | overdose, including, but not limited to, drug users, jail and | ||||||
9 | prison personnel, jail and prison inmates, drug treatment | ||||||
10 | professionals, emergency medical personnel, hospital staff, | ||||||
11 | families and associates of drug users, peace officers, | ||||||
12 | firefighters, public safety officers, needle exchange program | ||||||
13 | staff, and other interested people. In addition to information | ||||||
14 | regarding drug overdose prevention, recognition and response, | ||||||
15 | literature produced by the Department shall stress that drug | ||||||
16 | use remains illegal and highly dangerous and that complete | ||||||
17 | abstinence from illegal drug use is the healthiest choice. | ||||||
18 | (b) The Director shall provide advice to State and local | ||||||
19 | officials on the growing drug overdose crisis, including the | ||||||
20 | prevalence of drug overdose incidents, trends in drug overdose | ||||||
21 | incidents, and solutions to the drug overdose crisis. | ||||||
22 | Section 20. Grants. | ||||||
23 | (a) The Director shall award grants, in accordance with | ||||||
24 | this Section, to support local drug overdose prevention, | ||||||
25 | recognition, and response projects. Municipal health | ||||||
26 | departments, correctional institutions, and community-based | ||||||
27 | organizations may apply to the Department for a grant pursuant | ||||||
28 | to this Section at such time and in such manner as the Director | ||||||
29 | prescribes. | ||||||
30 |
(b) In awarding grants, the Director shall consider the | ||||||
31 | necessity for overdose prevention projects in various settings | ||||||
32 | and shall encourage all grant applicants to develop | ||||||
33 | interventions that will be effective and viable in their local | ||||||
34 | areas. |
| |||||||
| |||||||
1 |
(c) The Director shall give preference for grants to | ||||||
2 | proposals that, in addition to providing life-saving | ||||||
3 | interventions and responses, provide information to drug users | ||||||
4 | on how to access drug treatment or other strategies for | ||||||
5 | abstaining from illegal drugs. The Director shall give | ||||||
6 | preference to proposals that include one or more of the | ||||||
7 | following elements: | ||||||
8 | (1) policies and projects to encourage people, | ||||||
9 | including drug users, to call 9-1-1 when they witness a | ||||||
10 | potentially fatal drug overdose; | ||||||
11 | (2) drug overdose prevention, recognition and response | ||||||
12 | education projects in jails, prisons, drug treatment | ||||||
13 | centers, and other organizations that work with, or have | ||||||
14 | access to, drug users, their families and communities; | ||||||
15 | (3) drug overdose recognition and response training, | ||||||
16 | including rescue breathing, in jails, prisons, drug | ||||||
17 | treatment centers, and other organizations that work with, | ||||||
18 | or have access to, drug users, their families and | ||||||
19 | communities; | ||||||
20 | (4) the production and distribution of targeted or mass | ||||||
21 | media materials on drug overdose prevention and response; | ||||||
22 | (5) naloxone hydrochloride prescription or | ||||||
23 | distribution projects; | ||||||
24 | (6) the institution of education and training projects | ||||||
25 | on drug overdose response and treatment for emergency | ||||||
26 | services and law enforcement personnel; or | ||||||
27 | (7) a system of parent, family, and survivor education | ||||||
28 | and mutual support groups.
| ||||||
29 | The Director shall seek grants from private foundations, | ||||||
30 | the federal government, and other sources to fund the grants | ||||||
31 | under this Section and to fund an evaluation of the programs | ||||||
32 | supported by the grants.
| ||||||
33 | Section 25. Prescription; administration. A licensed | ||||||
34 | health care professional who is permitted by law to prescribe | ||||||
35 | an opioid antagonist, if acting with reasonable care, may |
| |||||||
| |||||||
1 | prescribe, dispense, distribute, or administer an opioid | ||||||
2 | antagonist without being liable for damages in a civil action | ||||||
3 | or subject to criminal prosecution.
| ||||||
4 | Section 99. Effective date. This Act takes effect upon | ||||||
5 | becoming law.
|